| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 89, 975-990, Copyright © 1994 by American Heart Association
WL Haskell, EL Alderman, JM Fair, DJ Maron, SF Mackey, HR Superko, PT Williams, IM Johnstone, MA Champagne and RM Krauss
BACKGROUND: Recent clinical trials have shown that modification of plasma
lipoprotein concentrations can favorably alter progression of coronary
atherosclerosis, but no data exist on the effects of a comprehensive
program of risk reduction involving both changes in lifestyle and
medications. This study tested the hypothesis that intensive multiple risk
factor reduction over 4 years would significantly reduce the rate of
progression of atherosclerosis in the coronary arteries of men and women
compared with subjects randomly assigned to the usual care of their
physician. METHODS AND RESULTS: Three hundred men (n = 259) and women (n =
41) (mean age, 56 +/- 7.4 years) with angiographically defined coronary
atherosclerosis were randomly assigned to usual care (n = 155) or
multifactor risk reduction (n = 145). Patients assigned to risk reduction
were provided individualized programs involving a low-fat and -cholesterol
diet, exercise, weight loss, smoking cessation, and medications to
favorably alter lipoprotein profiles. Computer-assisted quantitative
coronary arteriography was performed at baseline and after 4 years. The
main angiographic outcome was the rate of change in the minimal diameter of
diseased segments. All subjects underwent medical and risk factor
evaluations at baseline and yearly for 4 years, and reasons for all
hospitalizations and deaths were documented. Of the 300 subjects
randomized, 274 (91.3%) completed a follow-up arteriogram, and 246 (82%)
had comparative measurements of segments with visible disease at baseline
and follow-up. Intensive risk reduction resulted in highly significant
improvements in various risk factors, including low-density lipoprotein
cholesterol and apolipoprotein B (both, 22%), high-density lipoprotein
cholesterol (+12%), plasma triglycerides (-20%), body weight (-4%),
exercise capacity (+20%), and intake of dietary fat (- 24%) and cholesterol
(-40%) compared with relatively small changes in the usual-care group. No
change was observed in lipoprotein(a) in either group. The risk-reduction
group showed a rate of narrowing of diseased coronary artery segments that
was 47% less than that for subjects in the usual-care group (change in
minimal diameter, -0.024 +/- 0.066 mm/y versus -0.045 +/- 0.073 mm/y; P
< .02, two-tailed). Three deaths occurred in each group. There were 25
hospitalizations in the risk-reduction group initiated by clinical cardiac
events compared with 44 in the usual-care group (rate ratio, 0.61; P = .05;
95% confidence interval, 0.4 to 0.9). CONCLUSIONS: Intensive multifactor
risk reduction conducted over 4 years favorably altered the rate of luminal
narrowing in coronary arteries of men and women with coronary artery
disease and decreased hospitalizations for clinical cardiac events.
ARTICLES
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP)
Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA 94304-1583.
This article has been cited by other articles:
![]() |
J. Ma, K. Berra, W. L. Haskell, L. Klieman, S. Hyde, M. W. Smith, L. Xiao, and R. S. Stafford Case Management to Reduce Risk of Cardiovascular Disease in a County Health Care System Arch Intern Med, November 23, 2009; 169(21): 1988 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aucott, H. Rothnie, L. McIntyre, M. Thapa, C. Waweru, and D. Gray Long-Term Weight Loss From Lifestyle Intervention Benefits Blood Pressure?: A Systematic Review Hypertension, October 1, 2009; 54(4): 756 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Leon and U. G. Bronas Pathophysiology of Coronary Heart Disease and Biological Mechanisms for the Cardioprotective Effects of Regular Aerobic Exercise American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 379 - 385. [Abstract] [PDF] |
||||
![]() |
A Lucia, A De La Rosa, M A. Silvan, L M Lopez-Mojares, A Boraita, M Perez, C Foster, J Garcia-Castro, and M Ramirez Mobilisation of mesenchymal cells in cardiac patients: is intense exercise necessary? Br. J. Sports Med., March 1, 2009; 43(3): 221 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Charlson, J. C. Peterson, C. Boutin-Foster, W. M. Briggs, G. G. Ogedegbe, C. E. McCulloch, J. Hollenberg, C. Wong, and J. P. Allegrante Changing health behaviors to improve health outcomes after angioplasty: a randomized trial of net present value versus future value risk communication Health Educ. Res., October 1, 2008; 23(5): 826 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Belardinelli, F. Lacalaprice, C. Ventrella, L. Volpe, and E. Faccenda Waltz Dancing in Patients With Chronic Heart Failure: New Form of Exercise Training Circ Heart Fail, July 1, 2008; 1(2): 107 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Baca and G. R. Warnick Estimation of LDL-Associated Apolipoprotein B from Measurements of Triglycerides and Total Apolipoprotein B Clin. Chem., May 1, 2008; 54(5): 907 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Taylor, J. Bindeman, I. Feuerstein, T. Le, K. Bauer, C. Byrd, H. Wu, and P. G. O'Malley Community-Based Provision of Statin and Aspirin After the Detection of Coronary Artery Calcium Within a Community-Based Screening Cohort J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1337 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lennon, A. Carey, N. Gaffney, J. Stephenson, and C. Blake A pilot randomized controlled trial to evaluate the benefit of the cardiac rehabilitation paradigm for the non-acute ischaemic stroke population Clinical Rehabilitation, February 1, 2008; 22(2): 125 - 133. [Abstract] [PDF] |
||||
![]() |
H. R. Superko and S. King III Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required Circulation, January 29, 2008; 117(4): 560 - 568. [Full Text] [PDF] |
||||
![]() |
A. Wister PhD, N. Loewen MD, H. Kennedy-Symonds MHSc, B. McGowan MD, B. McCoy MA, and J. Singer PhD One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk Can. Med. Assoc. J., October 9, 2007; 177(8): 859 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Singh, M. H. Shishehbor, and B. J. Ansell High-Density Lipoprotein as a Therapeutic Target: A Systematic Review JAMA, August 15, 2007; 298(7): 786 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Rooke Controversies in vascular screening art versus science Vascular Medicine, August 1, 2007; 12(3): 235 - 242. [Abstract] [PDF] |
||||
![]() |
V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease) Circulation, December 19, 2006; 114(25): 2850 - 2870. [Full Text] [PDF] |
||||
![]() |
L. H. Kuller Prevention of Coronary Heart Disease and the National Cholesterol Education Program Circulation, February 7, 2006; 113(5): 598 - 600. [Full Text] [PDF] |
||||
![]() |
M. E. Clouse, J. Chen, H. M. Krumholz, M. E. Clouse, J. Chen, and H. M. Krumholz Noninvasive Screening for Coronary Artery Disease With Computed Tomography Is Useful Circulation, January 3, 2006; 113(1): 125 - 146. [Full Text] [PDF] |
||||
![]() |
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Clark, L. Hartling, B. Vandermeer, and F. A. McAlister Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease Ann Intern Med, November 1, 2005; 143(9): 659 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abrams Chronic Stable Angina N. Engl. J. Med., June 16, 2005; 352(24): 2524 - 2533. [Full Text] [PDF] |
||||
![]() |
R. K Oka, E. Umoh, A. Szuba, J. C Giacomini, and J. P Cooke Suboptimal intensity of risk factor modification in PAD Vascular Medicine, May 1, 2005; 10(2): 91 - 96. [Abstract] [PDF] |
||||
![]() |
A. S. Leon, B. A. Franklin, F. Costa, G. J. Balady, K. A. Berra, K. J. Stewart, P. D. Thompson, M. A. Williams, and M. S. Lauer Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease: An American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation Circulation, January 25, 2005; 111(3): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Roberts and R. J. Barnard Effects of exercise and diet on chronic disease J Appl Physiol, January 1, 2005; 98(1): 3 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Flemming and R. D. Brown Jr Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors Mayo Clin. Proc., October 1, 2004; 79(10): 1330 - 1340. [Abstract] [PDF] |
||||
![]() |
S.-F. Wong, J. G Jakowatz, and R. Taheri Management of Hypertriglyceridemia in Patients Receiving Interferon for Malignant Melanoma Ann. Pharmacother., October 1, 2004; 38(10): 1655 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Krauss Lipids and Lipoproteins in Patients With Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1496 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bandura Health Promotion by Social Cognitive Means Health Educ Behav, April 1, 2004; 31(2): 143 - 164. [Abstract] [PDF] |
||||
![]() |
R. Hambrecht, C. Walther, S. Mobius-Winkler, S. Gielen, A. Linke, K. Conradi, S. Erbs, R. Kluge, K. Kendziorra, O. Sabri, et al. Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial Circulation, March 23, 2004; 109(11): 1371 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Lear, A. Ignaszewski, W. Linden, A. Brozic, M. Kiess, J. J. Spinelli, P. Haydn Pritchard, and J. J. Frohlich The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial Eur. Heart J., November 1, 2003; 24(21): 1920 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Toobert, R. E. Glasgow, L. A. Strycker, M. Barrera Jr., J. L. Radcliffe, R. C. Wander, and J. D. Bagdade Biologic and Quality-of-Life Outcomes From the Mediterranean Lifestyle Program: A randomized clinical trial Diabetes Care, August 1, 2003; 26(8): 2288 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Niebauer, A. J. Maxwell, P. S. Lin, D. Wang, P. S. Tsao, and J. P. Cooke NOS inhibition accelerates atherogenesis: reversal by exercise Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H535 - H540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Jain, V Wadehra, and A D Timmis Management of stable angina Postgrad. Med. J., June 1, 2003; 79(932): 332 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. O'Malley, I. M. Feuerstein, and A. J. Taylor Impact of Electron Beam Tomography, With or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile: A Randomized Controlled Trial JAMA, May 7, 2003; 289(17): 2215 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Williams, J. R. Kaplan, I. H. Suparto, J. L. Fox, and S. B. Manuck Effects of Exercise on Cardiovascular Outcomes in Monkeys With Risk Factors for Coronary Heart Disease Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 864 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men Arterioscler Thromb Vasc Biol, February 14, 2003; 23(2): 314 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Graves and P. M. Miller Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease Behav Modif, January 1, 2003; 27(1): 3 - 25. [Abstract] [PDF] |
||||
![]() |
B. C. Bock, R. E. Carmona-Barros, J. L. Esler, and P. L. Tilkemeier Program Participation and Physical Activity Maintenance after Cardiac Rehabilitation Behav Modif, January 1, 2003; 27(1): 37 - 53. [Abstract] [PDF] |
||||
![]() |
References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text] |
||||
![]() |
P. Di Napoli, A.A. Taccardi, M. Oliver, and R. De Caterina Statins and stroke: evidence for cholesterol-independent effects Eur. Heart J., December 2, 2002; 23(24): 1908 - 1921. [PDF] |
||||
![]() |
D. J. Toobert, L. A. Strycker, R. E. Glasgow, M. Barrera, and J. D. Bagdade Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial Health Educ. Res., October 1, 2002; 17(5): 574 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Charlson, J. P. Allegrante, P. S. McKinley, J. C. Peterson, C. Boutin-Foster, G. Ogedegbe, and C. R. Young Improving health behaviors and outcomes after angioplasty: using economic theory to inform intervention Health Educ. Res., October 1, 2002; 17(5): 606 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ades, T. E. Kottke, N. Houston Miller, J. C. McGrath, N. B. Record, and S. S. Record Task Force #3--getting results: who, where, and how? J. Am. Coll. Cardiol., August 21, 2002; 40(4): 615 - 630. [Full Text] [PDF] |
||||
![]() |
M. Matsuzaki, K. Hiramori, T. Imaizumi, A. Kitabatake, H. Hishida, M. Nomura, T. Fujii, I. Sakuma, K. Fukami, T. Honda, et al. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: The Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART) J. Am. Coll. Cardiol., July 17, 2002; 40(2): 220 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Franklin, K. Bonzheim, J. Warren, S. Haapaniemi, N. Byl, and N. Gordon Effects of a Contemporary, Exercise-Based Rehabilitation and Cardiovascular Risk-Reduction Program on Coronary Patients With Abnormal Baseline Risk Factors* Chest, July 1, 2002; 122(1): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Lacy, D.-C. Suh, J. A. Barone, M. Bueno, D. Moylan, C. Swartz, R. V. Kudipudi, and J. B. Kostis Impact of a Targeted Intervention on Lipid-Lowering Therapy in Patients With Coronary Artery Disease in the Hospital Setting Arch Intern Med, February 25, 2002; 162(4): 468 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A McAlister, F. M E Lawson, K. K Teo, and P. W Armstrong Randomised trials of secondary prevention programmes in coronary heart disease: systematic review BMJ, October 27, 2001; 323(7319): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Denollet and D. L. Brutsaert Reducing Emotional Distress Improves Prognosis in Coronary Heart Disease: 9-Year Mortality in a Clinical Trial of Rehabilitation Circulation, October 23, 2001; 104(17): 2018 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Fihn, S. V. Williams, J. Daley, and R. J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Treatment Ann Intern Med, October 16, 2001; 135(8_Part_1): 616 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Fletcher, G. J. Balady, E. A. Amsterdam, B. Chaitman, R. Eckel, J. Fleg, V. F. Froelicher, A. S. Leon, I. L. Pina, R. Rodney, et al. Exercise Standards for Testing and Training: A Statement for Healthcare Professionals From the American Heart Association Circulation, October 2, 2001; 104(14): 1694 - 1740. [Full Text] [PDF] |
||||
![]() |
P. A. Ades Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease N. Engl. J. Med., September 20, 2001; 345(12): 892 - 902. [Full Text] [PDF] |
||||
![]() |
A Baessler, C Hengstenberg, S Holmer, M Fischer, B Mayer, U Hubauer, G Klein, G Riegger, and H Schunkert Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A case-control study in pairs of siblings with myocardial infarction Eur. Heart J., July 1, 2001; 22(13): 1111 - 1118. [Abstract] [PDF] |
||||
![]() |
T.D. Barringer Dietary fats in the prevention of coronary heart disease: the need for more clinical trials Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D79 - D84. [Abstract] [PDF] |
||||
![]() |
H. S. Hecht and H. R. Superko Electron beam tomography and national cholesterol education program guidelines in asymptomatic women J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1506 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-M. Lee, S. N. Blair, D. B. Allison, A. R. Folsom, T. B. Harris, J. E. Manson, and R. R. Wing Epidemiologic Data on the Relationships of Caloric Intake, Energy Balance, and Weight Gain Over the Life Span With Longevity and Morbidity J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2001; 56(90001): 7 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.N Willich, J Muller-Nordhorn, M Kulig, S Binting, H Gohlke, H Hahmann, K Bestehorn, K Krobot, and H Voller Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study Eur. Heart J., February 2, 2001; 22(4): 307 - 313. [Abstract] [PDF] |
||||
![]() |
E. J Parks A targeted goal for energy-restricted diets in the management of coronary risk? Am. J. Clinical Nutrition, February 1, 2001; 73(2): 147 - 148. [Full Text] [PDF] |
||||
![]() |
F. B. Hu, J. E. Manson, and W. C. Willett Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review J. Am. Coll. Nutr., February 1, 2001; 20(1): 5 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Lakka, J. A. Laukkanen, R. Rauramaa, R. Salonen, H.-M. Lakka, G. A. Kaplan, and J. T. Salonen Cardiorespiratory Fitness and the Progression of Carotid Atherosclerosis in Middle-Aged Men Ann Intern Med, January 2, 2001; 134(1): 12 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gielen, G. Schuler, and R. Hambrecht Exercise Training in Coronary Artery Disease and Coronary Vasomotion Circulation, January 2, 2001; 103 (1): e1 - e6. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Fodor, J. J. Frohlich, J. J.G. Genest Jr., P. R. McPherson, and for the Working Group on Hypercholesterolemia and Recommendations for the management and treatment of dyslipidemia: Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias Can. Med. Assoc. J., May 16, 2000; 162(10): 1441 - 1447. [Full Text] [PDF] |
||||
![]() |
R. Hambrecht, A. Wolf, S. Gielen, A. Linke, J. Hofer, S. Erbs, N. Schoene, and G. Schuler Effect of Exercise on Coronary Endothelial Function in Patients with Coronary Artery Disease N. Engl. J. Med., February 17, 2000; 342(7): 454 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.F.M. Van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A.M. Erdman, and M.L. Simoons Impact of smoking cessation and smoking interventions in patients with coronary heart disease Eur. Heart J., December 2, 1999; 20(24): 1773 - 1782. [PDF] |
||||
![]() |
T. M. Rywik, M. R. Blackman, A. R. Yataco, P. V. Vaitkevicius, R. C. Zink, E. H. Cottrell, J. G. Wright, L. I. Katzel, and J. L. Fleg Enhanced endothelial vasoreactivity in endurance-trained older men J Appl Physiol, December 1, 1999; 87(6): 2136 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hofman-Bang, J. Lisspers, R. Nordlander, A. Nygren, O. Sundin, A. Ohman, and L. Ryden Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme Eur. Heart J., October 2, 1999; 20(20): 1465 - 1474. [Abstract] [PDF] |
||||
![]() |
A. Kleemann, S. Eckert, A. von Eckardstein, W. Lepper, U. Schernikau, U. Gleichmann, P. Hanrath, E. Fleck, A. Neiss, S. Kerber, et al. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT) Eur. Heart J., October 1, 1999; 20(19): 1393 - 1406. [Abstract] [PDF] |
||||
![]() |
H. V. Huikuri, V. Jokinen, M. Syvanne, M. S. Nieminen, K. E. J. Airaksinen, M. J. Ikaheimo, J. M. Koistinen, H. Kauma, A. Y. Kesaniemi, S. Majahalme, et al. Heart Rate Variability and Progression of Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1979 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Herbert, M. Miller, S. A. Lear, and D. Ornish Effect of Lifestyle Changes on Coronary Heart Disease JAMA, July 14, 1999; 282(2): 130 - 132. [Full Text] [PDF] |
||||
![]() |
L. Campeau, D. B. Hunninghake, G. L. Knatterud, C. W. White, M. Domanski, S. A. Forman, J. S. Forrester, N. L. Geller, F. L. Gobel, J. A. Herd, et al. Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors : NHLBI Post Coronary Artery Bypass Graft Clinical Trial Circulation, June 29, 1999; 99(25): 3241 - 3247. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF] |
||||
![]() |
C. von Schacky, P. Angerer, W. Kothny, K. Theisen, and H. Mudra The Effect of Dietary {omega}-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, April 6, 1999; 130(7): 554 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Shephard and G. J. Balady Exercise as Cardiovascular Therapy Circulation, February 23, 1999; 99(7): 963 - 972. [Full Text] [PDF] |
||||
![]() |
H. C. Bucher, L. E. Griffith, and G. H. Guyatt Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 187 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rabbani and E. J. Topol Strategies to achieve coronary arterial plaque stabilization Cardiovasc Res, February 1, 1999; 41(2): 402 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ornish, L. W. Scherwitz, J. H. Billings, K. L. Gould, T. A. Merritt, S. Sparler, W. T. Armstrong, T. A. Ports, R. L. Kirkeeide, C. Hogeboom, et al. Intensive Lifestyle Changes for Reversal of Coronary Heart Disease JAMA, December 16, 1998; 280(23): 2001 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Buchwald, R. L. Varco, J. R. Boen, S. E. Williams, B. J. Hansen, C. T. Campos, G. S. Campbell, M. B. Pearce, A. E. Yellin, W. A. Edmiston, et al. Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH Arch Intern Med, June 8, 1998; 158(11): 1253 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Gartside, P. Wang, and C. J. Glueck Prospective Assessment of Coronary Heart Disease Risk Factors: The NHANES I Epidemiologic Follow-up Study (NHEFS) 16-Year Follow-up J. Am. Coll. Nutr., June 1, 1998; 17(3): 263 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Niebauer, R. Hambrecht, T. Velich, K. Hauer, C. Marburger, B. Kalberer, C. Weiss, E. von Hodenberg, G. Schlierf, G. Schuler, et al. Attenuated Progression of Coronary Artery Disease After 6 Years of Multifactorial Risk Intervention : Role of Physical Exercise Circulation, October 21, 1997; 96(8): 2534 - 2541. [Abstract] [Full Text] |
||||
![]() |
M. H. Frick, M. Syvanne, M. S. Nieminen, H. Kauma, S. Majahalme, V. Virtanen, Y. A. Kesaniemi, A. Pasternack, and M.-R. Taskinen Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol Circulation, October 7, 1997; 96(7): 2137 - 2143. [Abstract] [Full Text] |
||||
![]() |
H. G. Schrott, V. Bittner, E. Vittinghoff, D. M. Herrington, and S. Hulley Adherence to National Cholesterol Education Program Treatment Goals in Postmenopausal Women With Heart Disease: The Heart and Estrogen/Progestin Replacement Study (HERS) JAMA, April 23, 1997; 277(16): 1281 - 1286. [Abstract] [PDF] |
||||
![]() |
P. T. Williams, D. M. Dreon, P. J. Blanche, and R. M. Krauss Variability of Plasma HDL Subclass Concentrations in Men and Women Over Time Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 702 - 706. [Abstract] [Full Text] |
||||
![]() |
The Post Coronary Artery Bypass Graft Trial Invest The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts N. Engl. J. Med., January 16, 1997; 336(3): 153 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Miller, E. L. Alderman, W. L. Haskell, J. M. Fair, and R. M. Krauss Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention Project Circulation, November 1, 1996; 94(9): 2146 - 2153. [Abstract] [Full Text] |
||||
![]() |
P. S. Tsao, R. Buitrago, J. R. Chan, and J. P. Cooke Fluid Flow Inhibits Endothelial Adhesiveness: Nitric Oxide and Transcriptional Regulation of VCAM-1 Circulation, October 1, 1996; 94(7): 1682 - 1689. [Abstract] [Full Text] |
||||
![]() |
D. Waters, J. Lesperance, P. Gladstone, S. J. Boccuzzi, T. Cook, R. Hudgin, G. Krip, and L. Higginson Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy Circulation, August 15, 1996; 94(4): 614 - 621. [Abstract] [Full Text] |
||||
![]() |
G. F. Fletcher, G. Balady, S. N. Blair, J. Blumenthal, C. Caspersen, B. Chaitman, S. Epstein, E. S. S. Froelicher, V. F. Froelicher, I. L. Pina, et al. Statement on Exercise: Benefits and Recommendations for Physical Activity Programs for All Americans: A Statement for Health Professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association Circulation, August 15, 1996; 94(4): 857 - 862. [Full Text] |
||||
![]() |
M. Enriquez-Sarano, E. Klodas, K. N. Garratt, K. R. Bailey, A. J. Tajik, and D. R. Holmes Secular Trends in Coronary Atherosclerosis -- Analysis in Patients with Valvular Regurgitation N. Engl. J. Med., August 1, 1996; 335(5): 316 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Pedersen, J. Kjekshus, K. Berg, A. G. Olsson, L. Wilhelmsen, H. Wedel, K. Pyorala, T. Miettinen, T. Haghfelt, O. Færgeman, et al. Cholesterol Lowering and the Use of Healthcare Resources : Results of the Scandinavian Simvastatin Survival Study Circulation, May 15, 1996; 93(10): 1796 - 1802. [Abstract] [Full Text] |
||||
![]() |
A. A. Kroon, W. R.M. Aengevaeren, T. van der Werf, G. J.H. Uijen, J. H.C. Reiber, A. V.G. Bruschke, and A. F.H. Stalenhoef LDL-Apheresis Atherosclerosis Regression Study (LAARS) : Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis Circulation, May 15, 1996; 93(10): 1826 - 1835. [Abstract] [Full Text] |
||||
![]() |
M. Suurkula, S. Agewall, B. Fagerberg, I. Wendelhag, and J. Wikstrand Multiple Risk Intervention in High-Risk Hypertensive Patients : A 3-Year Ultrasound Study of Intima-Media Thickness and Plaques in the Carotid Artery Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 462 - 470. [Abstract] [Full Text] |
||||
![]() |
M. N. Hill and N. Houston Miller Compliance Enhancement : A Call for Multidisciplinary Team Approaches Circulation, January 1, 1996; 93(1): 4 - 6. [Full Text] |
||||
![]() |
L. Lacoste, J. Y.T. Lam, J. Hung, G. Letchacovski, C. B. Solymoss, and D. Waters Hyperlipidemia and Coronary Disease : Correction of the Increased Thrombogenic Potential With Cholesterol Reduction Circulation, December 1, 1995; 92(11): 3172 - 3177. [Abstract] [Full Text] |
||||
![]() |
D. Waters, L. Higginson, P. Gladstone, S. J. Boccuzzi, T. Cook, and J. Lesperance Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women : A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy Circulation, November 1, 1995; 92(9): 2404 - 2410. [Abstract] [Full Text] |
||||
![]() |
K. L. Gould, D. Ornish, L. Scherwitz, S. Brown, R. P. Edens, M. J. Hess, N. Mullani, L. Bolomey, F. Dobbs, W. T. Armstrong, et al. Changes in Myocardial Perfusion Abnormalities by Positron Emission Tomography After Long-term, Intense Risk Factor Modification JAMA, September 20, 1995; 274(11): 894 - 901. [Abstract] [PDF] |
||||
![]() |
J. J. Mason, D. K. Owens, R. A. Harris, J. P. Cooke, and M. A. Hlatky The Role of Coronary Angiography and Coronary Revascularization Before Noncardiac Vascular Surgery JAMA, June 28, 1995; 273(24): 1919 - 1925. [Abstract] [PDF] |
||||
![]() |
J. W. Jukema, A. V.G. Bruschke, A. J. van Boven, J. H.C. Reiber, E. T. Bal, A. H. Zwinderman, H. Jansen, G. J.M. Boerma, F. M. van Rappard, and K. I. Lie Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels : The Regression Growth Evaluation Statin Study (REGRESS) Circulation, May 15, 1995; 91(10): 2528 - 2540. [Abstract] [Full Text] |
||||
![]() |
D. Stokols, K. R. Pelletier, and J. E. Fielding Integration of Medical Care and Worksite Health Promotion JAMA, April 12, 1995; 273(14): 1136 - 1142. [Abstract] [PDF] |
||||
![]() |
A S Wierzbicki and T M Reynolds Health promotion in general practice BMJ, February 25, 1995; 310(6978): 532c - 533. [Full Text] |
||||
![]() |
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |